Pharmabiz

Nexalin Technology completes Q-Sub meeting with US FDA for Gen-2 SYNC neurostimulation console in Alzheimer’s disease programme

Nexalin Technology completes Q-Sub meeting with US FDA for Gen-2 SYNC neurostimulation console in Alzheimer’s disease programme: Houston, Texas Friday, December 5, 2025, 16:00 H ...
Pharmabiz

iOnctura initiates phase I/II trial of roginolisib in patients with myelofibrosis who are no longer responding to JAK inhibition

Onctura initiates phase I/II trial of roginolisib in patients with myelofibrosis who are no longer responding to JAK inhibition: Geneva, Switzerland Friday, December 5, 2025, 15: ...
Pharmabiz

Padma Awardee doctors’ issue national advisory urging immediate action on India’s air pollution health crisis

Padma Awardee doctors’ issue national advisory urging immediate action on India’s air pollution health crisis: Our Bureau, Mumbai Friday, December 5, 2025, 14:45 Hrs [IST] In ...
Pharmabiz

Rela Hospital saves life after heart stops by treating lung blood clots

Rela Hospital saves life after heart stops by treating lung blood clots: Our Bureau, Chennai Friday, December 5, 2025, 14:30 Hrs [IST] Rela Hospital in Chennai has successfully sa ...
Pharmabiz

ASG Eye Hospital to invest Rs. 2,000 crore towards expansion as part of Vision 2030

ASG Eye Hospital to invest Rs. 2,000 crore towards expansion as part of Vision 2030: Our Bureau, Mumbai Friday, December 5, 2025, 14:15 Hrs [IST] ASG Eye Hospital, India’s leadi ...
Pharmabiz

Terray Therapeutics gains drug discovery milestone in partnership with Bristol Myers Squibb

Terray Therapeutics gains drug discovery milestone in partnership with Bristol Myers Squibb: Los Angeles Friday, December 5, 2025, 14:00 Hrs [IST] Terray Therapeutics, a chemistry ...
Pharmabiz

Lupin receives US FDA tentative approval for siponimod tablets

Lupin receives US FDA tentative approval for siponimod tablets: Our Bureau, Mumbai Friday, December 5, 2025, 13:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced th ...
Pharmabiz

HiroPharmaConsulting’s AI-enabled reliability assurance method for pharmacovigilance systems receives Japanese patent

HiroPharmaConsulting’s AI-enabled reliability assurance method for pharmacovigilance systems receives Japanese patent: Osaka, Japan Friday, December 5, 2025, 13:00 Hrs [IST] Hir ...
Pharmabiz

mAbxience and HP drive the use of AI in biomanufacturing and biosimilar development

Abxience and HP drive the use of AI in biomanufacturing and biosimilar development: Madrid Friday, December 5, 2025, 12:00 Hrs [IST] mAbxience, a Fresenius entity, and HP Inc., a ...
Pharmabiz

Formycon & MS Pharma ink exclusive commercialization partnership for Keytruda biosimilar candidate FYB206 for MENA region

Formycon & MS Pharma ink exclusive commercialization partnership for Keytruda biosimilar candidate FYB206 for MENA region: Planegg-Martinsried, Germany Friday, December 5, 2025, 1 ...
Pharmabiz

AstraZeneca advances haematology and cell therapy ambition with largest-ever presence at ASH

AstraZeneca advances haematology and cell therapy ambition with largest-ever presence at ASH: Cambridge, UK Friday, December 5, 2025, 10:00 Hrs [IST] AstraZeneca, a global, scienc ...
Pharmabiz

Sanofi completes acquisition of Vicebio

Sanofi, an R&D driven, AI-powered biopharma company, announces the completion of its acquisition of Vicebio Ltd (Vicebio). This acquisition brings an early-stage combination vaccine candidate for ...